Corrigendum to: Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C
Authors:
Published: 2023-02-07
DOI:
10.1093/neuonc/noad026
Source:
Full article
Abstract
No abstract found.